1-4 of 4
David A. Frank, M.D., Ph.D.
Close
Sort by
Journal Articles

Pimozide Inhibits STAT5 Signaling in Chronic Myelogenous Leukemia and Reduces the Viability of Both Imatinib Sensitive and Imatinib Resistant Cells.

Erik A. Nelson, PhD, Sarah R. Walker, Ph.D., Alicia Kepich, B.S., Shariya Terrell, B.S., Laurie Gashin, B.S., David A. Frank, M.D., Ph.D.
Journal: Blood
Blood (2007) 110 (11): 2953.
https://doi.org/10.1182/blood.V110.11.2953.2953
Published: 2007
Journal Articles

Nifuroxazide Inhibits STAT3 Function and Shows Potent Anti-Tumor Activity Against Multiple Myeloma.

Erik A. Nelson, PhD, Teru Hideshima, M.D. Ph.D, Laurie Gashin, Sarah R. Walker, B.S., Rebecca A. Lynch, B.S., Dharminder Chauhan, Ph.D., Kenneth C. Anderson, M.D., David A. Frank, M.D.,Ph.D.
Journal: Blood
Blood (2006) 108 (11): 3450.
https://doi.org/10.1182/blood.V108.11.3450.3450
Published: 2006
Journal Articles

The Natural Product Honokiol Induces Caspase-Dependent Apoptosis in Chronic Lymphocytic Leukmemia (CLL) Cells.

Traci E. Battle, Ph.D., Jack Arbiser, M.D., Ph.D., David A. Frank, M.D., Ph.D.
Journal: Blood
Blood (2004) 104 (11): 4777.
https://doi.org/10.1182/blood.V104.11.4777.4777
Published: 2004
Journal Articles

Molecular Events Underlying the Induced Differentiation of CLL Cells Are Recapitulated in Cess B Cells.

Traci E. Battle, Ph.D., David A. Frank, M.D., Ph.D.
Journal: Blood
Blood (2004) 104 (11): 4778.
https://doi.org/10.1182/blood.V104.11.4778.4778
Published: 2004